Product Details
Auro-Febuxostat
Febuxostat80 mg
Tablet
DIN/PIN/NPN
02533243
Manufacturer
Auro Pharma Inc.
Formulary Listing Date
2023-05-31
Unit Price
1.3515
Amount MOH Pays
1.3515
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
M04AA03
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02357380 | Uloric | NA | NA |
02466198 | Teva-Febuxostat | 1.3515 | 1.3515 |
02473607 | Mar-Febuxostat | 1.3515 | 1.3515 |
02490870 | Jamp-Febuxostat | 1.3515 | 1.3515 |
02533243 | Auro-Febuxostat | 1.3515 | 1.3515 |
02539837 | Febuxostat | 1.3515 | 1.3515 |
LU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Gout | Febuxostat
To lower serum uric acid levels, where recommended according to clinical guidelines, in patients with gout or hyperuricemia meeting at least one of the following:
Patients who have experienced severe intolerances to allopurinol not meeting the above criteria will be considered on a case-by-case basis. Duration of approval: 1 year Renewal of funding will be considered for patients where there is objective evidence of clinical benefit from the use of febuxostat. |